Real-world application of currently available decision models for dual antiplatelet therapy duration in acute coronary syndrome

J Cardiovasc Med (Hagerstown). 2018 Jun;19(6):310-313. doi: 10.2459/JCM.0000000000000655.

Authors

Nuccia Morici^{1

2}, Enrico Piccinelli³, Dario Brunelli¹, Alice Sacco¹, Giovanna Viola¹, Jacopo A Oreglia¹, Fabrizio Oliva¹, Marco Valgimigli⁴

Affiliations

¹ De Gasperis Cardio Center, ASST Grande Ospedale Metropolitano Niguarda Ca' Granda.
² Department of Clinical Sciences and Community Health, Università degli Studi di Milano.
³ Health Science Department, Milano-Bicocca University, Milano, Italy.
⁴ Department of Cardiology, University Hospital of Bern, Bern, Switzerland.

PMID: 29601308
DOI: 10.2459/JCM.0000000000000655

No abstract available

Publication types

Letter

MeSH terms

Acute Coronary Syndrome / drug therapy*
Aged
Aged, 80 and over
Decision Support Techniques*
Drug Therapy, Combination
Female
Hemorrhage / etiology*
Humans
Male
Middle Aged
Platelet Aggregation Inhibitors / adverse effects
Platelet Aggregation Inhibitors / therapeutic use*
Retrospective Studies
Risk Assessment
Severity of Illness Index

Substances

Platelet Aggregation Inhibitors